Making Evidence-based Clinical Decisions. Paul L. Blackburn, BSN, MNA, RN, VA-BC

Similar documents
MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa

Describe the impact of CLABSI on patients and their families. Discuss three methods of reducing CLABSIs

Reducing Infection Risks Related to Vascular Access Devices: Competency and Training

Implementation Guide for Central Line Associated Blood Stream Infection

21 st Century Health Care Consultants

CENTRAL IOWA HEALTHCARE Marshalltown, Iowa

CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)

The dirty truth about IV access points. For full text documents, please contact customer support

See Policy #1302 (Nursing Student Privileges and Limitations) for full details. Central Line dressing care, declotting and discontinuation may ONLY

New research: Change peripheral intravenous catheters only as clinically

BRINGING THE PERIPHERY INTO FOCUS

Reducing Infection Risk At All Access Points

Patricia Church, MSN, RN, PCNS-BC, CPON Bernice Mowery, PhD, PNP, RN

Using Care Bundles to Reduce Catheter Associated Blood Stream Infections in the NICU. Dr David Ng Paediatric Medical Officer Sarawak General Hospital

2018 BSI QIA. Kick off Part 1. Annabelle Perez Quality Improvement Director

Clinical Evidence Summary. For full text documents, please contact customer support

2017 Nicolas E. Davies Enterprise Award of Excellence

THE JOURNEY TO CLINICAL INDICATION: TIME TO MOVE THE NEEDLE

SARASOTA MEMORIAL HOSPITAL NURSING PROCEDURE

MIDLINES/EXTENDED DWELL

Nursing Practice for Prevention of Central Line Associated Blood Stream Infection (CLABSI) in A Pediatric Intensive Care Unit

CHILDREN SUPPORTED BY MEDICAL TECHNOLOGY IN SCHOOLS: CARE AND MAINTENANCE OF CENTRAL VENOUS LINES

1. Nurses may remove non-tunneled catheters upon the order of a physician. Physicians remove tunneled catheters.

Venous Access Devices. Management of Central Venous Access Devices (CVADs) Central Venous Catheters. Outline. Implantable Port

Intravenous Medication Administration via a Central Venous Line

SARASOTA MEMORIAL HOSPITAL

Making Dialysis Safer for Patients Coalition

Request for Contact Hours 2017

Peripheral intravenous catheter performance: investigating peripheral intravenous catheter dwell times

INTERPROFESSIONAL PROTOCOL - MUHC

Objectives. Vessel Health and Preservation: Disclosure. Ms. Moureau has disclosed the following: Angiodynamics, Genentech

ASEPTIC TECHNIQUE LEARNING PACKAGE

Peripherally Inserted Central Catheter

The Nurse s Role in Preventing CLABSI

Nurses Role in CLABSI Prevention Do no harm Donna Matocha, DNP, MSN, CNRN, VA-BC

Healthcare-Associated Infections

PICCs. Vascular access is the cornerstone in the. It s all about. Vascular safety:

Centers for Disease Control and Prevention (CDC) Patient Hand Hygiene Audit Information and Instructions

Central Venous Access Devices (CVADs)

Department Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual

"Risky Business", Staff -Patient Safety Newsletter

HCA Infection Control Surveillance Survey

1. Infection Control, Centers for Disease Control and Prevention (CDC). (2002). Guideline for hand hygiene in health-care settings

Increasing attention to patient safety and changing to a

Central Line Bundle Education. National Patient Safety Goal Preventing Central Line Infections 2010

Objectives. Salem Health 11/1/2017. A Lean Journey to Reducing Central LineAssociated Bloodstream Infection (CLABSI) Rates

CLABSI Prevention Hardwiring Improvement

NURSING LEADERSHIP IMPACTING CHANGE

RN Entry Level Competency

Totally Implantable Venous Access Devices (port) Information for patients. Cross section of a port

NORTH SHORE MEDICAL CENTER NURSING PROCEDURE

Wyoming STATE BOARD OF NURSING

Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework

PC EP 4; PC EP 7. (Outpatient Only) If nutritional screen positive, plans for follow-up documented.

Peripheral IVs: THINK BIG. LOOK SMALL. Michelle DeVries MPH, CIC. Senior Infection Control Officer Methodist Hospitals Gary, Indiana

F E B R U A R Y 2 8, S C O T T F L A N D E R S, M D V I N E E T C H O P R A, M D

Arrow Vascular Clinical Education

WHY IMPLEMENT CENTRAL LINE INSERTION BUNDLES

CENTRAL VENOUS ACCESS DEVICE POLICY

CLABSI: Beyond the Policy and Procedure

Advanced Measurement for Improvement Prework

AREAS OF RESPONSIBILITY

LPN 8 Hour Didactic IV Education

North York General Hospital Policy Manual

Organization: Frederick Memorial Hospital. Solution Title: We Found the Missing Piece to Our CLABSI Puzzle

1.2 billion ambulatory care visits in US: physician offices, outpatient hospital and ED

Section Z - Blood Culture Policy. Version 4

STANDARDIZED PROCEDURE HEPATIC ARTERY INFUSION OF CHEMOTHERAPY (Adults, Peds)

The Global Quest for Practice-Based Evidence An Introduction to CALNOC

Central Venous Access Devices (CVADs) Hickman/Broviac and PICC Care Management Policy

Lessons From Infection Prevention Research in Emergency Medicine: Methods and Outcomes

Hospital Acquired Conditions. Tracy Blair MSN, RN

SARASOTA MEMORIAL HOSPITAL

Technology Innovations in Vascular Access

Central Venous Access Devices (CVAD) Procedures

How Do We Choose Optimal PIV Sites? Objectives. Good Vein, Bad Vein NIR & Choosing the Best IV Access Site. INS Site Choice Advice Key Points

Running head: EBN & CAUTIS 1

Section G - Aseptic Technique. Version 5

UPMC PASSAVANT Policy Manual. TITLE/SUBJECT: IntraOsseous Device POLICY NO:

Vascuport in Children for Routine Flushing and Administration of Medication

NURSING POLICIES, PROCEDURES & PROTOCOLS

The 2011 Infusion Nurses Society Standards of Practice

Arrow. Understanding Your Choice for Vascular Access. A patient guide to vascular access based on vessel health and preservation model

B.S.N., M.S., CRNI, CNSN

Abstract of thesis entitled. An evidence based guideline of using chlorhexidine gluconate impregnated dressing in

Objectives 31/07/2014. Peripheral IV Catheters: If clinically indicated replacement doesn t work, what will? Financial Disclosures

THE ROAD TO ZERO Reducing the incidence of central line associated bloodstream infections and needlestick injuries

Adopting Best Practice for Infusion Teams

Practice Guideline: Approval Date: May 11, 2017

HHVNA Infusion Therapy MIDLINE CATHETER

LESSON ASSIGNMENT. After completing this lesson, you should be able to: 2-3. Distinguish between medical and surgical aseptic technique.

Central Vascular Catheter Insertion Checklist Standard Operating Procedure. Perform optimal care

Personal Hygiene & Protective Equipment. NEO111 M. Jorgenson, RN BSN

Insertion of a PICC (Peripherally Inserted Central Catheter) / Mid Line

The 2016 INFUSION THERAPY STANDARDS. The Infusion Nurses Society (INS) publishes evidence-based practice 1.5

EAST CAROLINA UNIVERSITY INFECTION CONTROL POLICY

STANDARDIZED PROCEDURE CENTRAL LINE PLACEMENT and TEMPORARY NONTUNNELLED CENTRAL VENOUS DIALYSIS CATHETER INSERTION (Adult, Peds)

75,000 Approxiamte amount of deaths ,000 Number of patients who contract HAIs each year 1. HAIs: Costing Everyone Too Much

ROUGE VALLEY HEALTH SYSTEM PRACTICE STANDARDS MANUAL

INSIDE THE CURRENT ISSUE January 2013

Transcription:

Making Evidence-based Clinical Decisions Paul L. Blackburn, BSN, MNA, RN, VA-BC

Disclosures Senior Director of Marketing/Education RyMed Technologies President of the Board of Directors Association for Vascular Access (AVA) Share holder RyMed Technologies, Inc. C.R. Bard, Inc.

Agenda 1 Incidence of CR-BSI in the United States 2 Routes of contamination 3 4 How do clinicians fit into the picture? HATS model 5 Anatomy of a connector 6 Clinical evidence 7 Making an evidence-based clinical decision

CR-BSI in the U.S. 5 million central venous catheters (CVCs) inserted annually in the U.S. 1 87% of bloodstream infections (BSI) due to indwelling vascular catheters 2 Approximately 250,000 BSIs occur yearly 3 Approximately 50,000 deaths per year attributed to CRBSI 4 1. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003;348:1123-133. 2. Dariouiche R. Clin Infect Dis. 2001: 33: 1567-1572. 3. O Grady N., Alexnder M., Burns L., et al. Guidelines for the prevention of intravascular catheter-related infections, 2011. 4. Smith JSD, et al. J Infus Nurs. 2011: 34: 193-200

CR-BSI in the U.S. Cost per episode: $34,500-$56,000 5 ICU (general and adult ICU and adult surgical ICU) patient costs: $33,000-$75,000 6 $296 million --$2.3 billion annually 4 4. Smith JSD, et al. J Infus Nurs. 2011: 34: 193-200. 5. Moreau N. Nursing. 2009: 34: 14-15. 6. Hollenbeak CS. J Infus Nurs. 2011: 34: 309-311.

Agenda 1 Incidence of CR-BSI in the United States 2 Routes of contamination 3 4 How do clinicians fit into the picture? HATS model 5 Anatomy of a connector 6 Clinical Evidence 7 Making an evidence-based clinical decision

Routes of Infection The CR-BSI Cascade Two major causes of CLABSI 1. Bacteria from the skin migrate down the extraluminal surface of catheters, through the skin tract, and into the blood stream 7 2. Bacteria are introduced into the intraluminal surface of the catheter through manipulation of the needleless connector 7 7. Smith (2011) JIN 34:3 8. Maki D. (2004). Intensive Care Med, 30:62 9. Garland JS et al. (2008). ICHE, 29:243

The CR-BSI Cascade

Bacteria Adhere to Intraluminal Thrombus

Bacteria Adhere to Individual Fibrin Strands

Biofilm Growth

The Role of Biofilm in CR-BSI--Summary Relatively innocuous skin microbes can cause severe illness when attached to artificial devices in the body Fibrin coating has receptors allowing bacterial adhesion Bacteria grow and proliferate As the community matures, colonies are dispersed to insure survival of the species Manifesting as infectious symptoms

Increasing Incidence of CR-BSI Due to high occurrence of nosocomial contamination of needleless connectors 7 CDC recommends Disinfect connectors before use Scrubbing a connector for 15 seconds with 70% isopropyl alcohol prevents bacterial migration 7 7. Smith (2011) JIN 34:3

CR-BSI Trends The CDC has determined that, despite implementation of numerous prevention strategies, CR-BSIs have decreased by only 33% Patients with healthcare-associated infections have an increased risk of hospital readmissions

Agenda 1 Incidence of CR-BSI in the United States 2 Routes of contamination 3 4 How do clinicians fit into the picture? HATS model 5 Anatomy of a connector 6 Clinical Evidence 7 Making an evidence-based clinical decision

The Clinician Factor Other products impact CR-BSI Catheter site dressings Catheter stabilization devices Hub connectors Alcohol caps

The Clinician Factor Evaluations of poor patient outcomes evolved around patient and practice, with little or no thought of product 10 10 Chernecky (2013) JAVA 18:3

Agenda 1 Incidence of CR-BSI in the United States 2 Routes of contamination 3 4 How do clinicians fit into the picture? HATS model 5 Anatomy of a connector 6 Clinical evidence 7 Making an evidence-based clinical decision

Components of the HATS model Practice Patient Product 1. The model focuses on the interplay of three critical variables that influence patient care a. Patient b. Product c. Practice 2. Either alone or in combination, these variables affect patient outcomes. 3. If any of these three variables are not included in a study of patient outcomes, this may need to be addressed as a study limitation. Healthcare and Technology Synergy Model

What is a framework and why do we need one? Would you buy a car without a frame? How about a car kit, frame included, with no directions?

What is a framework and why do we need one? How can you tell what something is if it does not have a frame?

What is a framework and why do we need one? Could you live without your skeleton as a frame?

What is a framework and why do we need one? Conclusion: You need a frame on which to build Scientific research builds on frameworks which aids understanding of patient outcomes

How frameworks can be viewed Written word (ie: can declare if qualitative for data collection and analysis or if qualitative for theory) Map- interactions Diagram - simplicity

What frameworks do for vascular access research Guides studies in identifying nursing needs Provides meaningful knowledge that guides practice, not just because we do it that way Contributes to patient, society, and profession

Why we need a framework that incorporates product Evaluations of poor patient outcomes evolved around patient and practice If product is not a significant variable then why do we have product evaluations for computers, toasters, lamps, cars?

Is technology a significant variable in patient outcomes? Prevention of a majority of CRBSIs is obtainable but there is a need for prospective assessment of hazards associated with new technology (p. 1104) (Cardo et al, 2010)

Examples of uses of framework in types of nursing research Qualitative research Quantitative research Comparative effectiveness research (CER)

Comparative Effectiveness Research (CER) Designed to generate evidence in the real world Cost savings does not always equate with positive patient outcomes To ensure that populations health is enhanced comparative effectiveness research is necessary (Mushlin et al, 1998; Mushlin & Ghomrawi, 2010)

Example of CER in vascular access IV connector products differ on CFU growth and CRBSI rates Dr. Jarvis instructs us in his 2009 article Design Features Matter IV Connector products must have all 10 design features to significantly reduce occlusions and CR-BSI s

Agenda 1 Incidence of CR-BSI in the United States 2 Routes of contamination 3 4 How do clinicians fit into the picture? HATS model 5 Anatomy of a connector 6 Clinical evidence 7 Making an evidence-based clinical decision

Connector design Originally designed to meet OSHA mandate to implement products eliminating needle-stick injuries First universal, swabbable needleless I.V. connector introduced in early 1990s Effective in protecting healthcare workers from accidental needle-stick injuries

Connector Design Negative fluid displacement Must be swabbed with an antiseptic before use to maintain asepsis Draw small amount of fluid into catheter upon disconnect

Negative Fluid Displacement

Connector Design Positive Pressure Mechanical Valve Must be swabbed with antiseptic before each access to maintain asepsis Incorporate a positive fluid displacement feature that creates a bolus of fluid upon disconnection causes reflux upon connection

Positive Pressure Mechanical Valve

39 Connector Design Negative Displacement Valves Provides direct access to the fluid pathway Reflux of blood into catheter upon disconnection Blood coats wall of catheter lumen Fibrin begins to build-up Positive Pressure Mechanical Valves (PPMV) Refluxes blood immediately upon connection Blood coats wall of catheter lumen Fibrin begins to build-up Provides a positive push upon disconnection Minor reduction in occlusions Promotes repeated surface conditioning which may lead to intraluminal thrombotic occlusion

Connector Design Neutral fluid displacement Swab with antiseptic before each access to maintain asepsis Reduce the potential for reflux of blood into the catheter lumen upon connection or disconnection

Neutral Fluid Displacement

Summary IV connector products differ on CFU growth and CRBSI rates Dr. Jarvis instructs us in his 2009 article Design Features Matter IV Connector products must have all 10 design features to significantly reduce occlusions and CR-BSI s

44 Ideal design Septum surface Smooth external surface with few if any gaps Can be thoroughly disinfected Septum seal Tight seal between septum and connector housing Fluid pathway Direct/straight fluid pathway Facilitates adequate flushing Reduces internal surface biofilm development

45 Ideal design Dead space Little or no dead space in fluid pathway Minimize surfaces that infusates can contaminate and biofilm development Internal mechanism Direct and least tortuous fluid pathway No moving parts in fluid pathway Clamping sequence Does not require a clamping sequence

46 Ideal design Visibility Transparent fluid pathway Blood reflux Little or no blood reflux Flushing solution Flushed with saline-only

Agenda 1 Incidence of CR-BSI in the United States 2 3 Routes of contamination How do clinicians fit into the picture? 4 5 HATS model Anatomy of a connector 6 Clinical evidence 7 Making an evidence-based clinical decision

CR-BSI Reduction 9.7 Series 1 Invitro Migration p<0.0001 Mean numbers/day CFUs >= 15 On 4 types of organisms Clinical p<0.00046 Total PRE days: 56,346 Zero days: 65,653 Total study days:121,999 6.75 3.5 3.3 1.9 1.7 0.7 0.15 0.15 0.975 SPLIT SEPTUM NPMV PPMV 1.75 NPMV NEUTRAL NEUTRAL PPMV ZERO Original Zero APIC 2011

2013 Johns Hopkins Study Evaluating Intravenous Needleless Connectors: An Evidenced Based Practice Project Comprehensive market analysis with 19 needleless IV connectors identified and considered based on key factors: septum surface, septum seal, fluid pathway, dead space, internal mechanism, clamping sequence, visibility, blood reflux and flushing solution. RyMed Technologies InVision-Plus with Neutral Advantage IV connector was a clear leader, outperforming positive, negative and other neutral displacement needleless IV connectors (including ICU Medical s MicroClave in in-vivo studies). CR-BSIs were reduced by 33.3% at The Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital. Upon completion of this project, the hospital converted all central lines to the RyMed product. Additional findings include decreased use of Alteplase for declotting catheters in both the Oncology out-patient and inpatient settings. An average of 50% reduction in the use of Alteplase was noted during the evaluation. A complete list of 23 clinical studies conducted by top institutions can be found in the Appendix. These studies have been either published in specialized journals (e.g. the American Journal of Infection Control; Journal of the Association for Vascular Access; British Journal of Nursing) or presented as poster presentations at different congresses.

CR-BSI Reduction University of Louisville Hospital (2013) The CR-BSI rate decreased from 4.92 per 1000 catheter days to 3.13 per 1000 catheter days Equates to a 36% reduction of CR-BSIs in the Bone Marrow Transplant Unit

CR-BSI Reduction Protection of Intraluminal Pathway with Zero Fluid Displacement Connector Reduces Catheter-Related Bloodstream Infections in a Comprehensive Cancer Center Contamination of intraluminal pathway leads to CR-BSI Positive, negative displacement, and Split Septum devices linked to CR-BSI Zero fluid displacement decreased CR-BSI from 4.2 to 0.4/1000 catheter days6 months later, ICU CR-BSI from 2.24 to 0/1000 catheter days JAVA Vol 17, No 2, 2012 JAVA Vol 17, No 2, 2012

CR-BSI Reduction Achieving zero central line-associated blood stream infections: Connector design combined with practice in long-term acute care center 24,870 total catheter days Split Septum 10,479 6.0 Negative 4,257 3.3 Neutral 10,134 0.5 JAVA Vol 17, No 2, 2012

Occlusion Reduction PICC Occlusion Rates: Prospective study comparing positive pressure I.V. connector versus neutral displacement I.V. connector Using the neutral displacement IV connector and saline only flush resulted in: 21% unable to draw blood 15% sluggish to draw 12% totally occluded AVA 2006

Occlusion Reduction Clinical comparative evaluation of split-septum and zero fluid displacement connectors on central venous catheter occlusion ICU occlusion rate from 14.35 to 11.467/1000 catheter days (20%) Pediatric inpa ent from 101.62 to 54.87/1000 catheter days (46%) Pediatric outpa ent from 26.22 to 2.106/1000 catheter days (93%) All areas averaged a 73% in occlusion rates ONS 2011

Agenda 1 Incidence of CR-BSI in the United States 2 Routes of contamination 3 4 How do clinicians fit into the picture? HATS model 5 Anatomy of a connector 6 Clinical evidence 7 Making an evidence-based clinical decision

Evidence-based Practice Nursing research: a systematic process for inquiry that uses rigorous guidelines to produce unbiased, trustworthy answers to questions about nursing practice.

Evidence-based Practice Evidence-based practice is taking the best evidence, partnered with patient values and clinician judgment, to produce safer, higher-quality outcomes. Research practice

Evidence-based Practice According to the Institute of Medicine Learning Healthcare System nurses incorporate research into practice only 10% of the time 0nly 10% of what nurses do on a daily basis is based on any research or evidence

Evidenced-based Practice Moving toward an evidence-based practice culture Think about what is of particular interest Ask about joining other studies or help as a data collector Assist in the analysis of the data to increase comfort with the process

Evidenced-based Practice Moving toward an evidence-based practice culture Observe and question other nurses practice Encourage and support journal clubs Encourage and support staff participation in research and EBP projects

Translating Evidence-based Practice into Vascular access Carefully select a needleless connector based on design features, patient need, & clinical evidence Know type, design, technique required to use appropriately; benefits & risks of selected connector Utilize aseptic technique with each manipulation Disinfect the hub before each access Adhere to policy for connector changes Flush based on hospital policy and access type

THANK YOU!